Login / Signup

A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone.

Michael A WeberPeter SeverAttila JuhaszAndrew RobertsCharlie Cao
Published in: Journal of the renin-angiotensin-aldosterone system : JRAAS (2019)
Azilsartan medoxomil 40 mg or 80 mg plus chlorthalidone 25 mg was significantly more efficacious than chlorthalidone alone in reducing blood pressure and was well tolerated. Clinicaltrial.gov , https://clinicaltrials.gov/ct2/show/NCT00591773 , NCT00591773.
Keyphrases